Transcriptional Framework for the Molecular Diagnosis of Response to Immunotherapy in Lung Cancer With Agnostic Potential
NCT06807307
·
clinicaltrials.gov ↗
RECRUITING
Status
256
Enrollment
OTHER
Sponsor class
Conditions
NSCLC
Sponsor
Regina Elena Cancer Institute